Gabelli Healthcare & WellnessRx Trust Declares Third Quarter Distribution of $0.17 Per Share

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) declared a third-quarter cash distribution of $0.17 per share, payable on September 23, 2026 to shareholders of record on September 16, 2026. The Board intends to determine the distribution amount each quarter and may pay an additional adjusting distribution in December to meet regulated investment company requirements.

According to the Fund, preliminary 2026 distribution sources are estimated at approximately 11% net investment income, 47% net capital gains, and 42% return of capital on a book basis. The Trust is a diversified closed-end fund with $232 million in net assets, managed by Gabelli Funds, a subsidiary of GAMCO Investors (OTCQX: GAMI).

Positive

• $0.17 per share Q3 2026 cash distribution declared
• Payment and record dates set: September 23 and September 16, 2026
• Fund reports $232 million in total net assets

Negative

• Estimated 42% of 2026 distributions deemed return of capital
• Distribution policy can be modified or terminated at any time

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RYE, N.Y., Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & Wellness^Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.17 per share cash distribution payable September 23, 2026 to common shareholders of record on September 16, 2026.

The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.

Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently 20% in taxable accounts for individuals (or less depending on an individual’s tax bracket). In addition, certain U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their "net investment income", which includes dividends received from the Fund and capital gains from the sale or other disposition of shares of the Fund.

If the Fund does not generate sufficient earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.

Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro-rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, each of the distributions paid to common shareholders in 2026 would include approximately 11% from net investment income, 47% from net capital gains and 42% would be deemed a return of capital on a book basis. This does not represent information for tax reporting purposes. The estimated components of each distribution are updated and provided to shareholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). The final determination of the sources of all distributions in 2026 will be made after year end and can vary from the quarterly estimates. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution. All individual shareholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2026 distributions in early 2027 via Form 1099-DIV.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:

Bethany Uhlein
(914) 921-5546

About The Gabelli Healthcare & Wellness^Rx Trust
The Gabelli Healthcare & Wellness^Rx Trust is a diversified, closed-end management investment company with $232 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (OTCQX: GAMI).

NYSE: GRX
CUSIP – 36246K103

Investor Relations Contact: 
Bethany Uhlein
914.921.5546
buhlein@gabelli.com

FAQ

What dividend did Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) declare for the third quarter of 2026?

Gabelli Healthcare & WellnessRx Trust declared a $0.17 per share cash distribution for the third quarter of 2026. According to the Fund, it will be paid on September 23, 2026 to shareholders of record as of September 16, 2026.

When is the record date and payment date for the GRX Q3 2026 distribution?

The record date for the GRX third-quarter 2026 distribution is September 16, 2026, and the payment date is September 23, 2026. According to the Fund, shareholders on record at that time will receive a $0.17 per share cash payment.

How will Gabelli Healthcare & WellnessRx Trust (GRX) 2026 distributions be sourced?

Based on current accounting records, the Fund estimates 2026 distributions at about 11% from net investment income, 47% from net capital gains, and 42% as return of capital. According to the Fund, these figures are book estimates and may change at year-end.

Is the Gabelli Healthcare & WellnessRx Trust (GRX) distribution considered a dividend yield or total return?

The Fund states its distribution rate should not be viewed as dividend yield or total return. According to Gabelli Healthcare & WellnessRx Trust, shareholders should not infer investment performance from the current distribution amount, as components may include income, gains, and return of capital.

Can the distribution policy of Gabelli Healthcare & WellnessRx Trust (GRX) change?

Yes. According to the Fund, the distribution policy may be modified or terminated by the Board of Trustees at any time. The Board reviews potential distributions quarterly, considering income, realized capital gains, available capital, net asset value, and market conditions.

What are the tax implications of the 2026 GRX distributions for shareholders?

GRX distributions may be taxed as long-term capital gains, qualified dividend income, or return of capital, depending on their components. According to the Fund, final 2026 tax character will be reported on Form 1099-DIV to taxable U.S. shareholders in early 2027.

What is the size and management structure of Gabelli Healthcare & WellnessRx Trust (GRX)?

Gabelli Healthcare & WellnessRx Trust reports $232 million in total net assets and operates as a diversified closed-end management investment company. According to the Fund, it is managed by Gabelli Funds, a subsidiary of GAMCO Investors, traded as OTCQX: GAMI.